U.S. Markets closed

Dyax Corp. (DYAX) Soars: Stock Rises 6.7%

Zacks Equity Research

Dyax Corp. (DYAX) was a big mover last session, as its shares rose nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the healthcare company since Feb 6, as the stock is now up almost 41%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Dyax currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Emergent BioSolutions, Inc. (EBS) and Biogen Idec Inc. (BIIB). While Emergent BioSolutions sports a Zacks Rank #1 (Strong Buy), Cambrex and Biogen carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

DYAX CP (DYAX): Free Stock Analysis Report

Zacks Investment Research